Related references
Note: Only part of the references are listed.Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Mark K. Weng et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination
Robert S. Janssen et al.
VACCINE (2021)
Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations
Alex Hirst et al.
VACCINE (2021)
Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine
Catherine Stevenson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Prevalence of Hepatitis B Virus Exposure in the Veterans Health Administration and Association With Military-Related Risk Factors
Lauren A. Beste et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Hepatitis B seroprevalence in the US military and its impact on potential screening strategies
Paul T. Scott et al.
MILITARY MEDICINE (2020)
Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations
Elizabeth M. Rosenthal et al.
VACCINE (2020)
Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults
Katia Bruxvoort et al.
JAMA NETWORK OPEN (2020)
Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
Sam Jackson et al.
VACCINE (2018)
The US Military Commitment to vaccine Development: A Century of Successes and Challenges
Silvia Ratto-Kim et al.
FRONTIERS IN IMMUNOLOGY (2018)
Serosurveillance of First-Year Military Personnel for Hepatitis A and B
Michael Broderick et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine
Renee Kim Kuan et al.
VACCINE (2013)
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-4018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age
William L. Heyward et al.
VACCINE (2013)
Low Back Pain: Considerations for Rotary-Wing Aircrew
Steven John Gaydos
AVIATION SPACE AND ENVIRONMENTAL MEDICINE (2012)
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age
Scott A. Halperin et al.
VACCINE (2012)
Hepatitis B immunity in United States military recruits
PT Scott et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
An economic assessment of pre-vaccination screening for hepatitis A and B
RJ Jacobs et al.
PUBLIC HEALTH REPORTS (2003)
A comparative cost analysis of an integrated military telemental health-care service
BJ Grady
TELEMEDICINE JOURNAL AND E-HEALTH (2002)
Share Paper
